Treating morphologic and metabolic complications in HIV-infected patients on antiretroviral therapy. A consensus statement of an advisory committee of the International Association of Physicians in AIDS Care
- PMID: 15971353
Treating morphologic and metabolic complications in HIV-infected patients on antiretroviral therapy. A consensus statement of an advisory committee of the International Association of Physicians in AIDS Care
Abstract
Objective: Clinicians are increasingly challenged by presentation of morphologic and metabolic complications in HIV-infected patients. These complications are associated with HIV infection and/or combination antiretroviral therapy. This Consensus Statement is intended to offer guidance to clinicians actively involved in HIV/AIDS care.
Participants: Seven clinicians with expertise in HIV medicine were invited by the International Association of Physicians in AIDS Care (IAPAC) to serve on an ad hoc Advisory Committee.
Consensus process: IAPAC convened the Advisory Committee to develop a draft Consensus Statement. Each clinician was tasked with drafting a specific section of the Consensus Statement corresponding with his or her expertise around a morphologic and/or metabolic complication. Scientific and clinical research, and other data in published literature and abstracts from scientific conferences were considered by strength of evidence. This document represents the consensus agreement of the Advisory Committee.
Similar articles
-
Once-daily antiretroviral therapies for HIV infection: Consensus Statement of an Advisory Committee of the International Association of Physicians in AIDS Care.J Int Assoc Physicians AIDS Care (Chic). 2002 Oct-Dec;1(4):141-5. doi: 10.1177/154510970200100406. J Int Assoc Physicians AIDS Care (Chic). 2002. PMID: 12942673 Review.
-
The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support.Pediatrics. 2006 May;117(5):e955-77. doi: 10.1542/peds.2006-0206. Epub 2006 Apr 17. Pediatrics. 2006. PMID: 16618790
-
[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Enferm Infecc Microbiol Clin. 2009. PMID: 19246124 Spanish.
-
[HIV infection: antiretroviral therapy 1997. Consensus statement of the International AIDS Society-USA Panel].Med Monatsschr Pharm. 1997 Dec;20(12):343-6. Med Monatsschr Pharm. 1997. PMID: 9527604 Review. German. No abstract available.
-
Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.JAMA. 2002 Jul 10;288(2):222-35. doi: 10.1001/jama.288.2.222. JAMA. 2002. PMID: 12095387 Review.
Cited by
-
The Role of HIV Infection in the Pathophysiology of Gestational Diabetes Mellitus and Hypertensive Disorders of Pregnancy.Front Cardiovasc Med. 2021 May 12;8:613930. doi: 10.3389/fcvm.2021.613930. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34055923 Free PMC article. Review.
-
HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact.AIDS Res Ther. 2007 Jul 16;4:16. doi: 10.1186/1742-6405-4-16. AIDS Res Ther. 2007. PMID: 17634130 Free PMC article.
-
Understanding diabetes in patients with HIV/AIDS.Diabetol Metab Syndr. 2011 Jan 14;3(1):2. doi: 10.1186/1758-5996-3-2. Diabetol Metab Syndr. 2011. PMID: 21232158 Free PMC article.
-
Prevalence and characteristics of metabolic syndrome and its components among adults living with and without HIV in Nigeria: a single-center study.BMC Endocr Disord. 2023 Jul 28;23(1):160. doi: 10.1186/s12902-023-01419-x. BMC Endocr Disord. 2023. PMID: 37507703 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical